GlaxoSmithKline: The growth rate of R&D expenditure is expected to be significantly higher than the growth rate of sales in 2026.

Zhitongcaijing · 3d ago
GlaxoSmithKline: The growth rate of R&D expenditure is expected to be significantly higher than the growth rate of sales in 2026.